ATE204875T1 - Fungizide tetrahydrofurane - Google Patents

Fungizide tetrahydrofurane

Info

Publication number
ATE204875T1
ATE204875T1 AT95906620T AT95906620T ATE204875T1 AT E204875 T1 ATE204875 T1 AT E204875T1 AT 95906620 T AT95906620 T AT 95906620T AT 95906620 T AT95906620 T AT 95906620T AT E204875 T1 ATE204875 T1 AT E204875T1
Authority
AT
Austria
Prior art keywords
independently
tetrahydrofuranes
fungicidal
ester
polyestherester
Prior art date
Application number
AT95906620T
Other languages
English (en)
Inventor
Anil K Saksena
Viyyoor M Girijavallabhan
Raymond G Lovey
Russell E Pike
Haiyan Wang
Yi-Tsung Liu
Ashit K Ganguly
Frank Bennett
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22622452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE204875(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE204875T1 publication Critical patent/ATE204875T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
  • Lubricants (AREA)
AT95906620T 1993-12-21 1994-12-20 Fungizide tetrahydrofurane ATE204875T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17108393A 1993-12-21 1993-12-21
PCT/US1994/014236 WO1995017407A1 (en) 1993-12-21 1994-12-20 Tetrahydrofuran antifungals

Publications (1)

Publication Number Publication Date
ATE204875T1 true ATE204875T1 (de) 2001-09-15

Family

ID=22622452

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95906620T ATE204875T1 (de) 1993-12-21 1994-12-20 Fungizide tetrahydrofurane

Country Status (28)

Country Link
EP (1) EP0736030B1 (de)
JP (1) JP2834889B2 (de)
KR (1) KR0179990B1 (de)
CN (1) CN1064685C (de)
AT (1) ATE204875T1 (de)
AU (1) AU681753B2 (de)
BR (1) BR1100154B1 (de)
CA (1) CA2179396C (de)
CO (1) CO4520281A1 (de)
CZ (1) CZ294823B6 (de)
DE (2) DE69428125T2 (de)
DK (1) DK0736030T3 (de)
ES (1) ES2159623T3 (de)
FI (1) FI118470B (de)
FR (1) FR06C0009I2 (de)
HU (1) HU225062B1 (de)
IL (1) IL112081A (de)
LU (1) LU91216I2 (de)
MY (1) MY130217A (de)
NL (1) NL300219I2 (de)
NO (2) NO316173B1 (de)
NZ (1) NZ278713A (de)
PL (1) PL181193B1 (de)
PT (1) PT736030E (de)
SK (1) SK283035B6 (de)
TW (1) TW377349B (de)
WO (1) WO1995017407A1 (de)
ZA (1) ZA9410142B (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69513279T2 (de) * 1994-01-24 2000-07-13 Janssen Pharmaceutica N.V., Beerse Wasserlösliche azol-antifungus
HUP9701690A3 (en) * 1995-06-02 1998-04-28 Schering Corp Kenilwort Tetrahydrofuran derivatives as antifungals and pharmaceutical compositions containing the same
US5698557A (en) * 1995-06-19 1997-12-16 Schering Corporation Hydroxy-substituted antifungals
DE69629474T2 (de) * 1995-06-19 2004-06-24 Schering Corp. Antifungale tetrahydrofurane
DE69616596D1 (de) * 1995-12-20 2001-12-06 Schering Corp Verfahren zur herstellung von hydraziden
US5834472A (en) * 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
ZA974428B (en) * 1996-05-24 1997-11-24 Schering Corp Antifungal composition with enhanced bioavailability.
US5846971A (en) * 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
US5972381A (en) * 1996-06-28 1999-10-26 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability
WO1998000113A1 (en) * 1996-06-28 1998-01-08 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability
JP2000514059A (ja) * 1996-06-28 2000-10-24 シェーリング コーポレイション トリアゾール抗真菌化合物を含む経口組成物
EP0937071A1 (de) 1996-11-12 1999-08-25 Sepracor, Inc. 2r,4s,s,s- und 2s,4r,s,s-hydroxyitraconazol
CN1237173A (zh) * 1996-11-12 1999-12-01 塞普拉科公司 2r,4s,r,r-和2s,4r,r,r-羟基伊曲康唑
EP0942907A1 (de) * 1996-11-12 1999-09-22 Sepracor, Inc. 2r, 4s, s, r- and 2s, 4r, s, r-hydroxyitraconazle
WO1998021213A2 (en) * 1996-11-12 1998-05-22 Sepracor, Inc. 2r,4s,r,s- and 2s,4r,r,s-hydroxyitraconazole- and hydroxysaperconazole derivatives
US5684197A (en) * 1996-12-12 1997-11-04 Schering Corporation Process for preparation of hydrazides
CN1238353C (zh) * 1997-02-11 2006-01-25 詹森药业有限公司 含氨基酸酯之唑类抗真菌剂
PE120799A1 (es) * 1997-09-25 1999-12-01 Schering Corp Fosfato de tetrahidrofurano antifungal
US6043245A (en) * 1997-09-25 2000-03-28 Schering Corporation Tetrahydrofuran antifungal phosphate
DE69822859T2 (de) * 1997-10-07 2005-01-27 Schering Corp. Krytallinischer fungizider polymorph
WO1999018111A1 (en) * 1997-10-07 1999-04-15 Schering Corporation Crystalline antifungal glycine ester polymorph
US6713481B1 (en) * 1997-10-17 2004-03-30 David R. Andrews Crystalline antifungal polymorph
US5883097A (en) * 1998-04-16 1999-03-16 Schering Corporation Soluble azole antifungal salt
EP0957101A1 (de) 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Wasserlösliche Azole als Breitspektrum-antifungus
US6147077A (en) * 1999-04-29 2000-11-14 Sepracor Inc. 2R,4S-hydroxyitraconazole isomers
ID30409A (id) * 1999-05-04 2001-11-29 Jannsen Pharmaceutica N V Eter anti jamur
US6362172B2 (en) 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6448401B1 (en) 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
KR100607742B1 (ko) * 2001-04-03 2006-08-01 쉐링 코포레이션 안정한 액상 현탁제, 및 이를 함유하는, 생체 이용율이 증진된 항진균성 조성물
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
WO2003101392A2 (en) 2002-05-31 2003-12-11 Transform Pharmaceuticals, Inc. Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7446107B2 (en) 2002-02-15 2008-11-04 Transform Pharmaceuticals, Inc. Crystalline forms of conazoles and methods of making and using the same
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
EP1494998A2 (de) 2002-03-01 2005-01-12 University Of South Florida Mehrkomponenten festphasen enthaltend wenigstens einen pharmazeutischen wirkstoff
IL165383A0 (en) 2002-06-21 2006-01-15 Transform Pharmaceuticals Inc Pharmaceutical compositions with improved dissolution
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
ITMI20032020A1 (it) 2003-10-17 2005-04-18 Italfarmaco Spa Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
KR101289115B1 (ko) * 2004-08-13 2013-07-23 엠에스디 인터내셔널 홀딩즈 게엠베하 항생제인 트리아졸 및 코르티코스테로이드를 포함하는약제학적 제형
JO2691B1 (en) * 2005-05-03 2013-03-03 ايساي آر آند دي مانجمنت كو.، ليمتد Monolysine salts for azole compounds
EP2130540A1 (de) * 2008-06-02 2009-12-09 Sandoz AG Pharmazeutische Zusammensetzungen mit einer kristallinen Form von Posaconazol
EP2141159A1 (de) 2008-07-03 2010-01-06 Sandoz AG Kristalline Form von Posaconazol
CA2767489A1 (en) 2009-07-09 2011-01-13 Sandoz Ag A crystalline form of posaconazole
WO2011158248A2 (en) * 2010-05-12 2011-12-22 Glenmark Generics Limited Process for preparation of posaconazole and crystalline polymorphic form v of posaconazole
EP2571869B1 (de) 2010-05-19 2015-09-23 Sandoz AG Reinigung von posaconazol und posaconazol-zwischenprodukten
RU2580318C2 (ru) * 2010-05-19 2016-04-10 Сандоз Аг Получение промежуточных продуктов для синтеза позаконазола
US9040539B2 (en) 2010-05-19 2015-05-26 Sandoz Ag Process for the preparation of chiral triazolones
EP2571847B1 (de) 2010-05-19 2016-09-21 Sandoz AG Verfahren zur herstellung chiraler hydrazide
EP2588116A4 (de) 2010-06-29 2013-12-04 Merck Sharp & Dohme Durch substituiertes beta-cyclodextrin stabilisierte intravenöse posaconazollösungsformulierungen
US9493428B2 (en) 2011-06-16 2016-11-15 Sandoz Ag Process for the preparation of a chiral compound
EP2789610A1 (de) 2013-04-10 2014-10-15 Sandoz Ag Reinigung von Posaconazol-Zwischenprodukten
US9670188B2 (en) 2013-07-25 2017-06-06 Sandoz Ag Process for the preparation of crystalline form IV of posaconazole
ITMI20132114A1 (it) 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
CN105287403A (zh) * 2014-08-02 2016-02-03 陕西合成药业股份有限公司 一种泊沙康唑前体药物的冻干组合物及其制备方法和用途
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
ES2786374T3 (es) 2014-12-05 2020-10-09 Pulmocide Ltd Compuesto antimicótico
ES2790723T3 (es) 2015-05-21 2020-10-29 Pulmocide Ltd Antifúngico 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-il)metil)-5-(2,4-difluorofenil)tetrahidrofurano-3-il)metoxi)-3-metilfenil)piperazina-1-il)-N -(2-hidroxiciclohexil)benzamida, o una sal farmacéuticamente aceptable del mismo
CN106317032A (zh) * 2015-06-15 2017-01-11 重庆圣华曦药业股份有限公司 一种制备高纯度的泊沙康唑的方法
CN106432338A (zh) * 2015-08-08 2017-02-22 陕西合成药业股份有限公司 泊沙康唑衍生物、合成和在长效制剂中的用途
BR112018005934A2 (pt) * 2015-09-23 2018-10-09 Biocon Ltd formas cristalinas de intermediário de posaconazol e processo para a preparação de posaconazol amorfo
CN105606736A (zh) * 2016-01-27 2016-05-25 重庆华邦制药有限公司 分离测定泊沙康唑中间体z1及其有关物质的方法
WO2017147893A1 (zh) * 2016-03-04 2017-09-08 浙江奥翔药业股份有限公司 泊沙康唑、组合物、中间体及其制备方法和用途
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
EP3558304A2 (de) 2016-12-23 2019-10-30 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Inhibitoren des mitglieds 1 der unterfamilie b der cytochrom-p450-familie 7 (cyp7b1) zur verwendung in der behandlung von krankheiten
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
CN106967054A (zh) * 2017-03-30 2017-07-21 成都绿林科技有限公司 一种泊沙康唑的制备方法
CN106883221A (zh) * 2017-04-17 2017-06-23 兰州大学 一种无定形泊沙康唑及其制备方法
CN108341754A (zh) * 2018-03-12 2018-07-31 扬子江药业集团有限公司 泊沙康唑杂质及其制备方法和用途
CN110938093B (zh) * 2018-09-21 2022-08-19 华创合成制药股份有限公司 一种泊沙康唑磷酸酯单胆碱盐及其制备方法和用途
CN112778369B (zh) * 2019-11-05 2024-01-26 华创合成制药股份有限公司 一种三唑类衍生物及其制备方法和用途
GB201917867D0 (en) 2019-12-06 2020-01-22 Pulmocide Ltd Polymorphs
CN113666915B (zh) * 2021-08-27 2022-08-16 江苏海洋大学 一种泊沙康唑中间体的制备方法
CN114315811B (zh) * 2021-11-19 2024-04-30 江苏恒盛药业有限公司 一种三氮唑类似物化合物及其制备方法和应用
CN120794964A (zh) * 2025-07-03 2025-10-17 广州绿十字制药股份有限公司 泊沙康唑脂肪酸酯、泊沙康唑脂肪酸酯脂肪乳及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
AU2811689A (en) * 1987-11-20 1989-06-14 Schering Corporation Tri-and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
US5039676A (en) * 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals

Also Published As

Publication number Publication date
MY130217A (en) 2007-06-29
IL112081A0 (en) 1995-03-15
LU91216I2 (en) 2006-03-27
ZA9410142B (en) 1996-05-02
FI118470B (fi) 2007-11-30
IL112081A (en) 2001-08-26
NO316173B1 (no) 2003-12-22
NZ278713A (en) 1997-12-19
AU1512795A (en) 1995-07-10
FR06C0009I2 (de) 2006-12-29
HK1008820A1 (en) 1999-05-21
CN1142828A (zh) 1997-02-12
EP0736030B1 (de) 2001-08-29
DE122006000004I2 (de) 2007-03-29
NL300219I2 (nl) 2006-05-01
FI962577A0 (fi) 1996-06-20
FI962577L (fi) 1996-06-20
DK0736030T3 (da) 2001-10-29
NO962616D0 (no) 1996-06-20
NL300219I1 (nl) 2006-04-03
NO2006002I1 (no) 2006-02-20
TW377349B (en) 1999-12-21
SK283035B6 (sk) 2003-02-04
PL315169A1 (en) 1996-10-14
CA2179396C (en) 2001-04-17
NO2006002I2 (no) 2011-03-07
BR1100154B1 (pt) 2013-11-26
DE69428125D1 (de) 2001-10-04
CZ180596A3 (en) 1997-01-15
ES2159623T3 (es) 2001-10-16
AU681753B2 (en) 1997-09-04
KR0179990B1 (en) 1999-03-20
CO4520281A1 (es) 1997-10-15
JPH09500658A (ja) 1997-01-21
EP0736030A1 (de) 1996-10-09
SK82696A3 (en) 1997-03-05
DE122006000004I1 (de) 2006-04-27
PL181193B1 (pl) 2001-06-29
HU9601709D0 (en) 1996-08-28
CZ294823B6 (cs) 2005-03-16
FR06C0009I1 (de) 2006-05-19
PT736030E (pt) 2002-01-30
WO1995017407A1 (en) 1995-06-29
NO962616L (no) 1996-08-07
DE69428125T2 (de) 2002-05-02
CN1064685C (zh) 2001-04-18
CA2179396A1 (en) 1995-06-29
JP2834889B2 (ja) 1998-12-14
HUT75879A (en) 1997-05-28
HU225062B1 (en) 2006-05-29

Similar Documents

Publication Publication Date Title
ATE204875T1 (de) Fungizide tetrahydrofurane
YU164791A (sh) Nezasićene hidroksialkilhinolin kiseline
ATE306261T1 (de) Antithrombosemittel
IL133623A0 (en) Antithrombotic agents
EA199600104A1 (ru) Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты
MX9701229A (es) Antifungicos de tetrahidrofurano.
ATE247108T1 (de) Antifungale tetrahydrofurane
AU8226891A (en) Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
AU8889998A (en) Water soluble analogs and prodrugs of paclitaxel
PT81556B (pt) Processo para a preparacao de agentes anti-fungicos de triazole
ES2140531T3 (es) Inhibidor de la interleucina-1.
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
AR003437A1 (es) Un compuesto antifungico de tetrahidrofurano, una composicion farmaceutica que los contiene, su uso para preparar un medicamento antifungico y una sal deester aminoacido del mismo